There is a high degree of variability in the management and even the understanding of the oligometastatic state in lung malignancies, or indeed in the context of any solid tumor.

Modern trends throughout radiation oncology have favored short-course hypofractionated regimens which are frequently more cost-effective and convenient for patients. Over the past two years, multiple prospective studies have emerged supporting hypofractionation in soft tissue sarcoma.

There is increasing use of sentinel lymph node biopsy in gynecologic cancers but how best to integrate this information into post-operative radiation treatment recommendations is not always clear. This includes how to interpret isolated tumor cells, micrometastasis, and macrometastasis.

The introduction of novel therapies for gynecologic malignancies such as immunotherapy, SBRT and complex brachytherapy can lead to increased frequency of severe toxicities for which treatment options may be limited.

Breast cancer is the most diagnosed cancer in women. The most commonly diagnosed form of breast cancer in the United States is early-stage breast cancer, for which there are outstanding outcomes.

Lung cancer screening is resulting in a higher incidence of early-stage lung cancer diagnoses. This commonly occurs among older patients with chronic lung disease who are at high risk for complications with attaining pathologic confirmation.